9-128322930-C-G
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PVS1_StrongPM2PP5_Moderate
The NM_016035.5(COQ4):c.70+2C>G variant causes a splice donor, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000137 in 1,601,364 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 1/1 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★).
Frequency
Consequence
NM_016035.5 splice_donor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COQ4 | NM_016035.5 | c.70+2C>G | splice_donor_variant, intron_variant | ENST00000300452.8 | NP_057119.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COQ4 | ENST00000300452.8 | c.70+2C>G | splice_donor_variant, intron_variant | 1 | NM_016035.5 | ENSP00000300452.3 | ||||
COQ4 | ENST00000372875.3 | c.70+2C>G | splice_donor_variant, intron_variant | 2 | ENSP00000361966.3 | |||||
COQ4 | ENST00000608951.5 | c.70+2C>G | splice_donor_variant, intron_variant | 2 | ENSP00000476323.1 | |||||
COQ4 | ENST00000609948.1 | c.70+2C>G | splice_donor_variant, intron_variant | 2 | ENSP00000477292.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152248Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000544 AC: 12AN: 220716Hom.: 0 AF XY: 0.0000487 AC XY: 6AN XY: 123206
GnomAD4 exome AF: 0.0000145 AC: 21AN: 1449116Hom.: 0 Cov.: 30 AF XY: 0.0000166 AC XY: 12AN XY: 720964
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152248Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74378
ClinVar
Submissions by phenotype
Neonatal encephalomyopathy-cardiomyopathy-respiratory distress syndrome Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | May 22, 2023 | In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. ClinVar contains an entry for this variant (Variation ID: 476189). This variant has not been reported in the literature in individuals affected with COQ4-related conditions. This variant is present in population databases (rs767839639, gnomAD 0.02%). This sequence change affects a donor splice site in intron 1 of the COQ4 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in COQ4 are known to be pathogenic (PMID: 25658047). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at